|Articles|July 11, 2012
Cost Implications of Pertuzumab/Trastuzumab Combination
In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
5 Things to Know About the Oral GLP-1 Era
5
